ECOG Performance StatusW0180pembrolizumabsquamous cell carcinoma
…y and unknown (n=1 each).CPS, combined positive score; ECOG PS, Eastern Cooperative Oncology Group performance status; PD-1, programmed cell death protein-1; PD-L1, programmed death…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 2 of 2459Benfotiamine
…2.879)−3.542 (13.781)16.128 (6.086 to 26.170)0.003TPP effect (%)Benfotiamine (24)Placebo (27)12.975 (7.915)13.667 (7.063)4.217 (5.008)13.104…
CKD
…les (HR: 0.86, 95% CI: 0.75 to 0.99, p=0.035) exhibited reduced CKD risks, with no significant interaction between the sexes (p for…
99.0%
Visual Analogue Scalechronic low back paindiabetesparacetamolhypertension
…ently occurring scale for each outcome (back pain and leg pain, visual analogue scale 0-100; disability, Oswestry disability index 0-100; mental heal…
type 2 diabetes
…n (IQR) of 12.5 (11.8–13.2) years, 423 (3.2%) participants with type 2 diabetes and 2758 (0.9%) participants without diabetes developed MALO. P…
Visual Analogue ScaleNumeric Rating ScaleparacetamolDutch Healthcare Instituteinflammatory bowel disease
…49.7)0.92±0.1672 (47.7)−0.04 (−0.08 to 0.00)0.044EQ-5D-3L Proxy visual analogue scale (scale 0 to 100) Baseline55.2±24.163 (41.7)55.5±21.164 (42.4)0.…
semaglutidedulaglutide
…intensification or change was 1.6 (0.7) and 1.4 (0.7) years for semaglutide and alternative treatment, with no subgroup differences noted (…
type 2 diabetesGLP-1RAacute pancreatitismetforminpancreatitis
…9 30Cohort construction We identified 620 168 participants with type 2 diabetes who received at least one prescription for GLP-1RA or sulfonylu…
Postpartum haemorrhagetranexamic acid
…Introduction Postpartum haemorrhage, or excessive bleeding after childbirth, is the leading cause o…
testicular cancerepididymo-orchitisTC
…for UTI, unspecified/site not specified. ICD diagnosis code for testicular cancer: 178 (ICD-7).Cystitis is a lower urinary tract infection.Bold v…
type 2 diabetescardiovascular diseaseStrategiesmetforminsemaglutideglimepirideGLP-1RAsGLP-1RAmajor adverse cardiovascular events
…rt selection. We identified 620 168 Veterans Affairs users with type 2 diabetes who used GLP-1RAs or sulfonylureas between 1 January 2017 and 3…
sickle cell diseasebreast cancerattention deficit hyperactivity disordermenopausecardiovascular diseasecardiovascular disease25Sickle cell disease746
…sts about how HRT might affect health outcomes.44 45 Women with sickle cell disease have a higher risk of blood clots46 (an increased risk with ora…